Julie Kim, MD
Associate Professor
Medicine
School of Medicine

Julie Kim, MD is an associate clinical professor in Division of Endocrinology and Diabetes at UCSF. Dr. Kim practices at San Francisco General Hospital and treats patients with a variety of endocrinology conditions and diabetes. She has a particular interest in quality improvement, in order to provide better patient care while improving provider work flow and efficiency through the use of technology. She is also interested in inpatient diabetes and glucose management.

Education & Training

Show all (4) Hide

• BS Biological Sciences Stanford University
• Fellowship Endocrinology University of California, Los Angeles (UCLA)
• MD Medicine University of California, Los Angeles (UCLA)
• Residency Internal Medicine University of California, San Francisco (UCSF)

Interests

Show all (5) Hide

• clinical informatics
• quality improvement
• population health
• general endocrinology
• diabetes

Publications (6)

Top publication keywords:
HyperalgesiaMorphineTenofovirReceptors, GlutamateTechnologyRenal Insufficiency, ChronicFatal OutcomeSerumUrinary Bladder NeoplasmsParathyroid Hormone-Related ProteinPropranololRNA Processing, Post-TranscriptionalHypercalcemiaBicarbonatesAnti-HIV Agents

• Two uncommon cases of parathyroid hormone-related peptide mediated hypercalcemia in bladder carcinoma.
  Endocrinologia, diabetes y nutricion 2018 Kim JE, Martinez D
• A Review of Technology-Assisted Interventions for Diabetes Prevention.
  Current diabetes reports 2017 Grock S, Ku JH, Kim J, Moin T
• Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
  AIDS (London, England) 2016 Kim JE, Scherzer R, Estrella MM, Ix JH, Shlipak MG
• Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain.
  Pain 2012 Chu LF, D'Arcy N, Brady C, Zamora AK, Young CA, Kim JE, Clemenson AM, Angst MS, Clark DJ
• Modulation of remifentanil-induced postinfusion hyperalgesia by the β-blocker propranolol in humans.
  Pain 2012 Chu LF, Cun T, Ngai LK, Kim JE, Zamora AK, Young CA, Angst MS, Clark DJ
• GRLD-1 regulates cell-wide abundance of glutamate receptor through post-transcriptional regulation.
  Nature neuroscience 2010 Wang GJ, Kang L, Kim JE, Maro GS, Xu XZ, Shen K